He is also the Director of the Stanford Behavioral and Functional Neuroscience Laboratory (SBFNL). He has an extensive background in CNS drug discovery and preclinical development. His aim is to understand normal and pathological brain function in neurodegenerative diseases and to develop novel therapeutic approaches for treatment of these disorders